The 2015 ARCS Sydney Scientific Congress will once again offer one of the premier events of the year for professionals in the development and commercialisation of therapeutics. [ + ]

Researchers from Johns Hopkins University have delved into the history of the diabetes drug insulin in the hope of understanding why a generic version has never been made available in the US. [ + ]

The Queensland Department of Agriculture and Fisheries (DAF) has officially opened the 2015 Hermitage Research Facility Schools Plant Science Competition - an annual event that aims to stimulate an interest in agriculture and science in young Australians. [ + ]

The Australian scientific research vessel Investigator, which was commissioned into service in December 2014, will this week embark on its maiden research voyage. [ + ]

University of Queensland researchers have discovered that non-invasive ultrasound technology can be used to treat Alzheimer's disease and restore memory in mice, breaking apart the neurotoxic amyloid-β (Aβ) plaques that result in cognitive decline.

A research collaboration between Griffith University and New Zealand's Malaghan Institute has discovered that mitochondria are capable of passing through the healthy membrane of a host cell into defective tumour cells.

Scientists from Sweden's Karolinska Institutet have explained the mysterious mechanism which protects people with blood type O from dying of severe malaria. [ + ]

Scientists from Sweden's Karolinska Institutet have explained the mysterious mechanism which protects people with blood type O from dying of severe malaria. [ + ]

QIAGEN has expanded its portfolio of liquid biopsies through the acquisition of an innovative technology that enables enrichment and molecular analysis of circulating tumour cells (CTCs) from blood samples. [ + ]

Flinders University researchers are undertaking a project to reduce urinary tract infections associated with the use of catheters during hospital stays. [ + ]

Korean biotechnology company ToolGen will license its CRISPR/Cas9 intellectual property portfolio to Thermo Fisher Scientific. Thermo Fisher will utilise the technology to develop and market CRISPR reagent kits. [ + ]

Engineers from the University of Rhode Island have created a paper-based platform for conducting a wide range of complex medical diagnostics. Fluid-actuated valves, which are embedded in the paper, allow for the sequential manipulation of sample fluids and reagents in a controlled manner. [ + ]

Korean biotechnology company ToolGen will license its CRISPR/Cas9 intellectual property portfolio to Thermo Fisher Scientific. Thermo Fisher will utilise the technology to develop and market CRISPR reagent kits. [ + ]

Corgenix Medical Corporation and Fio Corporation are working together to integrate two technological advances to help end the Ebola outbreak in West Africa. [ + ]

Researchers from Sydney's Garvan Institute have developed CaptureSeq - a gene sequencing technology that is said to explore the human genome at a much higher resolution than ever before.